Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

GGHCX vs RYHIX overlap: 52% of top holdings shared

Bottom line

How much do GGHCX and RYHIX overlap?

52% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 45.5% of GGHCX's assets and 20.6% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

GGHCXRYHIX
Weight overlap (top 25)52%
Shared holdings11
Weight in shared holdings45.5%20.6%
Total positions82135
Expense ratio1.07%1.38%
Holdings as ofJul 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Holdings GGHCX and RYHIX have in common

Holding% of GGHCX% of RYHIXOverlap
Eli Lilly and Co.10.59%3.63%3.63%
Johnson & Johnson6.76%2.88%2.88%
UnitedHealth Group Inc.6.17%2.22%2.22%
Merck & Co., Inc.4.59%2.04%2.04%
AbbVie Inc.4.03%2.52%2.52%
Gilead Sciences, Inc.3.63%1.39%1.39%
CVS Health Corp.2.52%1.31%1.31%
Cardinal Health, Inc.2.10%0.86%0.86%
Vertex Pharmaceuticals Inc.2.01%1.34%1.34%
Edwards Lifesciences Corp.1.56%0.84%0.84%
Thermo Fisher Scientific Inc.1.55%1.61%1.55%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in GGHCX

  1. Invesco Private Prime Fund — 4.67%
  2. argenx SE — 3.24%
  3. Welltower Inc. — 2.34%
  4. BrightSpring Health Services, Inc. — 2.20%
  5. Royalty Pharma PLC — 2.13%
  6. Guardant Health, Inc. — 2.04%
  7. Invesco Private Government Fund — 1.80%
  8. Axsome Therapeutics, Inc. — 1.58%
  9. Invesco Treasury Portfolio — 1.56%
  10. BridgeBio Pharma, Inc. — 1.43%
  11. Waters Corp. — 1.41%
  12. IQVIA Holdings Inc. — 1.32%
  13. U C B S.a. — 1.24%
  14. Ligand Pharmaceuticals Inc. — 1.18%

Only in RYHIX

  1. Amgen Inc — 1.56%
  2. Abbott Laboratories — 1.42%
  3. Intuitive Surgical Inc — 1.31%
  4. Danaher Corp — 1.30%
  5. Pfizer Inc — 1.25%
  6. Bristol-myers Squibb Company — 1.22%
  7. Stryker Corp — 1.21%
  8. Mckesson Corp — 1.05%
  9. Elevance Health Inc — 1.02%
  10. Cigna Group (the) — 0.94%
  11. Regeneron Pharmaceuticals Inc — 0.90%
  12. Hca Healthcare Inc — 0.87%
  13. Boston Scientific Corp — 0.86%
  14. Novo Nordisk A/s — 0.83%

Asset mix

Asset typeGGHCXRYHIX
Stocks97.5%83.2%
Cash & short-term funds8.8%—
Repurchase agreements—0.9%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Country mix

CountryGGHCXRYHIX
US93.5%73.0%
NL3.4%0.7%
IE0.6%3.3%
GB3.1%1.8%
CH2.7%2.3%
DK1.1%1.4%
BE1.2%—
IL0.4%0.6%

Source: SEC Form N-PORT (periods Jul 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do GGHCX and RYHIX overlap?
About 52% by weight. 11 securities appear in both funds' top 25 holdings; they make up 45.5% of GGHCX's assets and 20.6% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do GGHCX and RYHIX have in common?
The largest shared holdings are Eli Lilly and Co., Johnson & Johnson, AbbVie Inc., UnitedHealth Group Inc., Merck & Co., Inc..
Should I own both GGHCX and RYHIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, GGHCX or RYHIX?
RYHIX is broader, with 135 positions versus 82 for GGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.